Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Corey

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
CCL Family Foundations|July 1, 1994
Showdown in CairoW Corey
CCL Family Foundations|November 1, 1994
The United Nations Population Fund and Planned Parenthood proudly present the International Conference on Population and DevelopmentW Corey
Antimicrobial Agents and Chemotherapy|August 2, 2012
Antibacterial activities of iron chelators against common nosocomial pathogensMitchell G Thompson, Brendan W Corey, Yuanzheng Si, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|May 27, 2020
<i>Bacteroides Fragilis</i> Vertebral Osteomyelitis and Discitis: "Back" to Susceptibility TestingJohn C Chin, Tyler E Warkentien, Brendan W Corey, et al.
Current Protocols in Microbiology|November 5, 2014
Genetic Manipulation of Acinetobacter baumanniiAnna C Jacobs, Mitchell G Thompson, Michael Gebhardt, et al.
Journal of Clinical Microbiology|July 18, 2025
An open-source nanopore-only sequencing workflow for analysis of clonal outbreaks delivers short-read level accuracyNick Vereecke, Thomas B Yoon, Ting L Luo, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant <i>Acinetobacter baumannii</i>William M Huggins, Bradley M Minrovic, Brendan W Corey, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synergistic Killing and Re-Sensitization of <i>Pseudomonas aeruginosa</i> to Antibiotics by Phage-Antibiotic Combination TreatmentEmily Engeman, Helen R Freyberger, Brendan W Corey, et al.
Journal of Forensic Sciences|March 1, 1997
Evaluation of independence assumptions for PCR-based and protein-based genetic markers in New Jersey CaucasiansB Budowle, L B Jankowski, H W Corey, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseriFrancois Lebreton, Brendan W Corey, Christi L McElheny, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
CCL Family Foundations|July 1, 1994
Showdown in CairoW Corey
CCL Family Foundations|November 1, 1994
The United Nations Population Fund and Planned Parenthood proudly present the International Conference on Population and DevelopmentW Corey
Antimicrobial Agents and Chemotherapy|August 2, 2012
Antibacterial activities of iron chelators against common nosocomial pathogensMitchell G Thompson, Brendan W Corey, Yuanzheng Si, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|May 27, 2020
<i>Bacteroides Fragilis</i> Vertebral Osteomyelitis and Discitis: "Back" to Susceptibility TestingJohn C Chin, Tyler E Warkentien, Brendan W Corey, et al.
Current Protocols in Microbiology|November 5, 2014
Genetic Manipulation of Acinetobacter baumanniiAnna C Jacobs, Mitchell G Thompson, Michael Gebhardt, et al.
Journal of Clinical Microbiology|July 18, 2025
An open-source nanopore-only sequencing workflow for analysis of clonal outbreaks delivers short-read level accuracyNick Vereecke, Thomas B Yoon, Ting L Luo, et al.
ACS Medicinal Chemistry Letters|January 21, 2017
1,2,4-Triazolidine-3-thiones as Narrow Spectrum Antibiotics against Multidrug-Resistant <i>Acinetobacter baumannii</i>William M Huggins, Bradley M Minrovic, Brendan W Corey, et al.
Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synergistic Killing and Re-Sensitization of <i>Pseudomonas aeruginosa</i> to Antibiotics by Phage-Antibiotic Combination TreatmentEmily Engeman, Helen R Freyberger, Brendan W Corey, et al.
Journal of Forensic Sciences|March 1, 1997
Evaluation of independence assumptions for PCR-based and protein-based genetic markers in New Jersey CaucasiansB Budowle, L B Jankowski, H W Corey, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Characterization of KPC-82, a KPC-2 Variant Conferring Resistance to Ceftazidime-Avibactam in a Carbapenem-Nonsusceptible Clinical Isolate of Citrobacter koseriFrancois Lebreton, Brendan W Corey, Christi L McElheny, et al.
Pageof 3